Markt für nicht-invasive Beatmungsmasken – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00026524
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 188
Buy Now

Der Markt für nicht-invasive Beatmungsmasken wird voraussichtlich 2.583,06 Millionen US-Dollar im Jahr 2028 erreichen, ausgehend von einem geschätzten Wert von 1.776,04 Millionen US-Dollar im Jahr 2021. Der Markt wird von 2021 bis 2028 voraussichtlich um 5,5 % CAGR wachsen.< /h3>

Der Umfang des Marktes für nicht-invasive Beatmungsmasken umfasst das Produkt, den Typ, die Anwendung, den Endbenutzer und die Geografie. Basierend auf der Region ist der Markt für nicht-invasive Beatmungsmasken in Nordamerika, Europa, den asiatisch-pazifischen Raum, den Nahen Osten und Afrika sowie Süd- und Mittelamerika unterteilt. Der Bericht bietet Einblicke und eingehende Analysen des Marktes für nicht-invasive Beatmungsmasken und hebt verschiedene Parameter wie Markttrends und -chancen, Marktdynamik und Wettbewerbslandschaftsanalyse führender Marktteilnehmer in Nordamerika, Europa, Asien-Pazifik und dem Nahen Osten hervor Ost- und Afrika sowie Süd- und Mittelamerika. Es enthält auch eine COVID-19-Auswirkungsanalyse in den Regionen.



Strategische Erkenntnisse



Lukrative Regionen für den Markt für nicht-invasive Beatmungsmasken< /h3>

Market Insights Steigende Prävalenz von chronisch obstruktiven Lungenerkrankungen



Chronisch obstruktive Lungenerkrankungen sind nach wie vor eines der bedeutendsten Probleme der öffentlichen Gesundheit weltweit. Es ist die vierthäufigste Ursache für chronische Morbidität und Mortalität in den USA. So litten laut WHO im Jahr 2018 weltweit rund 75 Millionen Menschen an mittelschwerer bis schwerer COPD. Es wird erwartet, dass die Belastung durch COPDs weltweit in den nächsten zehn Jahren aufgrund der alternden Bevölkerung und der anhaltenden Exposition gegenüber Risikofaktoren zunehmen wird. Patienten mit zugrunde liegenden COPDs, die an einer Exazerbation ihrer Erkrankung und hyperkapnischer Dyspnoe oder respiratorischer Insuffizienz leiden, werden höchstwahrscheinlich erfolgreich mit nicht-invasiver Beatmung (NIV) behandelt. NIV entlastet effektiv die Atemmuskulatur, erhöht das Atemzugvolumen, verringert die Atemfrequenz und verringert die Arbeit der Zwerchfellatmung, was zu einer Verbesserung der Sauerstoffversorgung, einer Verringerung der Hyperkapnie und einer Verbesserung der Dyspnoe führt.



NIV trägt dazu bei, die Intubation und Mortalität bei Patienten mit COPD-Exazerbation mit respiratorischer Insuffizienz zu reduzieren. Die Art der Maske kann sich jedoch auf die Erfolgsrate auswirken. Für Patienten, die schwer krank sind und unter ARF leiden, wird eine Vollgesichtsmaske anstelle von Nasenmasken empfohlen. Am weitesten verbreitet ist die Mund-Nasen-Maske. Die zunehmende Prävalenz von COPDs hat den Bedarf an NIV-Masken erheblich erhöht, was den globalen Markt unterstützt.



Produktbasierte Einblicke



Basierend In Bezug auf das Produkt ist der Markt für nicht-invasive Beatmungsmasken in wiederverwendbare Masken für nicht-invasive Beatmung und Einwegmasken für nicht-invasive Beatmung unterteilt. Im Jahr 2021 führte das Segment der wiederverwendbaren Masken für die nicht-invasive Beatmung den Weltmarkt an, und dasselbe Segment wird voraussichtlich im Prognosezeitraum die höchste CAGR verzeichnen.



Nicht-invasive Beatmungsmasken Markt, nach Produkt - 2021 und 2028



Typbasierte Erkenntnisse



Der Markt für nicht-invasive Beatmungsmasken basiert auf dem Typ unterteilt in Nasenmaske, Vollgesichtsmaske und Vollgesichtsmaske. Das Segment der Vollgesichtsmasken wird voraussichtlich 2021 den größten Marktanteil halten, und dasselbe Segment wird im Prognosezeitraum Schätzungen zufolge die höchste CAGR auf dem Markt verzeichnen.



Anwendungsbasierte Einblicke



Basierend auf der Anwendung wird der Markt für nicht-invasive Beatmungsmasken in respiratorische Dysfunktion, chronisch obstruktive Lungenerkrankungen, Lungenentzündung und andere unterteilt. Das Segment der respiratorischen Dysfunktion hielt 2021 den größten Marktanteil und wird voraussichtlich die höchste CAGR im Prognosezeitraum melden.



Endnutzerbasierte Erkenntnisse


< TIPP>

Basierend auf dem Endbenutzer ist der Markt für nicht-invasive Beatmungsmasken in Intensivstation, Pädiatrie, häusliche Pflege und andere unterteilt. Das ICU-Segment hatte 2021 den größten Marktanteil. Das Segment der häuslichen Pflege wird jedoch im Prognosezeitraum wahrscheinlich die höchste CAGR auf dem Markt verzeichnen.



Unternehmen nehmen üblicherweise anorganische Strategien wie Fusionen und Übernahmen entwickeln, um der sich ändernden Kundennachfrage gerecht zu werden und ihren Markennamen weltweit aufrechtzuerhalten. Marktteilnehmer verfolgen auch organische Strategien wie Produkteinführung und -erweiterung, um ihre Präsenz und ihr Produktportfolio weltweit auszudehnen und der wachsenden Nachfrage gerecht zu werden.



Nach Produkt




  1. Wiederverwendbare Masken für nicht-invasive Beatmung

  2. Einwegmasken für nicht-invasive Beatmung


Nach Typ




  1. Nasenmaske

  2. Vollgesichtsmaske

  3. Total Face Mask



Nach Anwendung




  1. Chronisch obstruktive Lungenerkrankungen
  2. Atemstörung

  3. Lungenentzündung

  4. Andere



< h3>Nach Endbenutzer


  1. Pädiatrie

  2. Intensivstation

  3. Häusliche Pflege
  4. Andere



Nach Geografie




  1. Nordamerika

    1. USA

    2. Kanada

    3. Mexiko



  2. Europa

    1. Großbritannien

    2. Deutschland

    3. Frankreich
    4. Italien

    5. Spanien

    6. Benelux

    7. Rest von Europa




  3. Asien-Pazifik

    1. China

    2. Japan

    3. Indien

    4. Australien

    5. Südkorea

    6. Indonesien

    7. Thailand

    8. Singapur

    9. Malaysia

    10. Rest Asien-Pazifik



    < /li>
  4. Naher Osten und Afrika

    1. Saudi-Arabien

    2. Südafrika

    3. VAE

    4. Türkei

    5. Rest des Nahen Ostens und Afrikas




  5. Süd- und Mittelamerika

    1. Brasilien

    2. Argentinien

    3. Rest Süd- und Mittelamerika

    4. < /ol>




    Unternehmensprofile




    1. ResMed, Inc.

    2. Hamilton Medical

    3. Koninklijke Philips NV

    4. Fisher & Paykel Healthcare Ltd.
    5. < TIP>
    6. Air Liquide Medical Systems

    7. Dragerwerk KG & Co., KGaA

    8. Intersurgical Ltd.

    9. BMC Medizin

    10. DeVilbiss Healthcare LLC

    11. Vyaire Medical, Inc.

    12. ARMSTRONG MEDICAL



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which are the top companies that hold the market share in the non-invasive ventilation masks market?

ResMed, Inc., and Koninklijke Philips N.V. are the top two companies that hold huge market shares in the non-invasive ventilation masks market.

Which region is expected to witness significant demand for non-invasive ventilation masks market in the coming years?

Global non-invasive ventilation masks market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for non-invasive ventilation masks. The growth of this market is primarily driven by the growing geriatric population base suffering from respiratory diseases such as COPD is the primary driver of the market. The increasing acceptance of novel and innovative products and the availability of R&D grants accounts for significant revenue in the forecast period.

What is Non-Invasive Ventilation Masks?

Non-invasive ventilation masks are products that supports the patient's breathing without the need for intubation or a tracheotomy and used to provide non-invasive ventilation therapy. It delivers effective therapy with less risk of infection and high survival in patients with respiratory failure. The NIV therapy masks are convenient, comfortable, as well as effective. These are commonly used in hospitals, and home settings, as patient interfaces for non-invasive ventilators or positive airway pressure devices.

Which product led the non-invasive ventilation masks market?

The non-invasive ventilation reusable masks segment held the largest share of the market in the global non-invasive ventilation masks market contributing a market share of 72.28% in 2021.

What are the driving factors for the non-invasive ventilation masks market across the globe?

Key factors that are driving the growth of this market are the increasing prevalence of chronic obstructive pulmonary diseases and increase in infection across the globe which are expected to boost the market growth for the non-invasive ventilation masks over the years.

The List of Companies - Non-Invasive Ventilation Masks Market

  1. ResMed, Inc.
  2. Hamilton Medical
  3. Koninklijke Philips N.V.
  4. Fisher & Paykel Healthcare Ltd.
  5. Air Liquide Medical Systems
  6. Dragerwerk KG & Co., KGaA
  7. Intersurgical Ltd.
  8. BMC Medical
  9. DeVilbiss Healthcare LLC
  10. Vyaire Medical, Inc.
  11. ARMSTRONG MEDICAL

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports